Anti-thymocyte globulin at a total dose of 2.5mg/kg for acute graft-versus-host disease prophylaxis after unrelated haematopoietic stem cell transplantation for acute myelogenous leukaemia

被引：0
|
作者：
Min, W. S. [1 ]
Kim, H. J. [1 ]
Cho, B. S. [1 ]
Kim, Y. J. [1 ]
Min, C. K. [1 ]
Lee, S. [1 ]
Cho, S. G. [1 ]
Lee, J. W. [1 ]
Kim, C. C. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [31] FIVE VERSUS 2.5 MG/KG OF ANTI-THYMOCYTE-GLOBULIN DOSE IN REDUCED-INTENSITY-CONDITIONING REDUCES ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE FOR PATIENTS WITH MYELOID MALIGNANCIES UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Devillier, R.
    Crocchiolo, R.
    Castagna, L.
    Fuerst, S.
    El Cheikh, J.
    Faucher, C.
    Prebet, T.
    Etienne, A.
    Chabannon, C.
    Esterni, B.
    Blaise, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S338 - S338
  • [32] Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults
    Chakupurakal, Geothy
    Freudenberger, Paul
    Skoetz, Nicole
    Ahr, Hans
    Theurich, Sebastian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [33] Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults
    Theurich, Sebastian
    Fischmann, Hans
    Shimabukuro-Vornhagen, Alexander
    Chemnitz, Jens M.
    Holtick, Udo
    Scheid, Christof
    Skoetz, Nicole
    von Bergwelt-Baildon, Michael
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [34] Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
    Queralt Salas, Maria
    Atenafu, Eshetu G.
    Datt Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis
    Michelis, Fotios, V
    Gerbitz, Armin
    Howard Lipton, Jeffrey
    Mattsson, Jonas
    Kumar, Rajat
    Viswabandya, Auro
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 428.e1 - 428.e9
  • [35] Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation
    Masahiro Teramoto
    Satoshi Maruyama
    Hiroya Tamaki
    Katsuji Kaida
    Azusa Mayumi
    Keiko Fukunaga
    Takayuki Inoue
    Kyoko Yoshihara
    Satoshi Yoshihara
    Kazuhiro Ikegame
    Masaya Okada
    Yuko Osugi
    Hiroyasu Ogawa
    Satoshi Higasa
    Kunihiko Morita
    Kana Matsumoto
    Takashi Kijima
    International Journal of Hematology, 2022, 116 : 248 - 257
  • [36] Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation
    Teramoto, Masahiro
    Maruyama, Satoshi
    Tamaki, Hiroya
    Kaida, Katsuji
    Mayumi, Azusa
    Fukunaga, Keiko
    Inoue, Takayuki
    Yoshihara, Kyoko
    Yoshihara, Satoshi
    Ikegame, Kazuhiro
    Okada, Masaya
    Osugi, Yuko
    Ogawa, Hiroyasu
    Higasa, Satoshi
    Morita, Kunihiko
    Matsumoto, Kana
    Kijima, Takashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (02) : 248 - 257
  • [37] Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation
    Kean, Leslie S.
    Burns, Linda J.
    Kou, Tzuyung D.
    Kapikian, Roxanne
    Lozenski, Karissa
    Langston, Amelia
    Horan, John T.
    Watkins, Benjamin
    Qayed, Muna
    Bratrude, Brandi
    Betz, Kayla
    Tang, Xiao-Ying
    Zhang, Mei-Jie
    Connolly, Sean E.
    Polinsky, Martin
    Gavin, Brian
    Gomez-Caminero, Andres
    Pasquini, Marcelo C.
    BLOOD, 2024, 144 (17) : 1834 - 1845
  • [38] Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
    Takafumi Shichijo
    Shigeo Fuji
    Arnon Nagler
    Abdulhamid Bazarbachi
    Mohamad Mohty
    Bipin N. Savani
    Bone Marrow Transplantation, 2020, 55 : 505 - 522
  • [39] Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
    Shichijo, Takafumi
    Fuji, Shigeo
    Nagler, Arnon
    Bazarbachi, Abdulhamid
    Mohty, Mohamad
    Savani, Bipin N.
    BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 505 - 522
  • [40] Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia
    Medinger, Michael
    Heim, Dominik
    Gerull, Sabine
    Halter, Jorg
    Krenger, Werner
    Buser, Andreas
    Lengerke, Claudia
    Bucher, Christoph
    Passweg, Jakob
    LEUKEMIA RESEARCH, 2016, 47 : 22 - 25
12345